Investigating the Roles of MAPKs as Precision Oncology Targets: A Multi-cancer Expression and Survival Study.

Cancer Genomics Proteomics · 2025 · PMC12577606 · PMID 41151853

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Specifically, patients exhibiting high MAPK3 expression showed significantly reduced survival probabilities, with a hazard ratio (HR) of 1.91 and a highly significant p -value of 0.00018, indicating nearly twice the risk of death compared to those with low expression.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.